Dimethylarsinic acid (DMA) is a major metabolite of inorganic arsenicals in
mammals, and arsenic exposure is associated with tumor development in a wi
de variety of human tissues, particularly the skin. Transgenic mice with or
nithine decarboxylase (ODC) targeted to hair follicle keratinocytes are muc
h more sensitive than littermate controls to carcinogens. In this study we
investigated the promoting effect of DR DMA on skin carcinogenesis in such
K6/0DC transgenic mice. The back skin of female C57BL/6J k6/0DC transgenic
mice, 10 to 14 weeks old, was initiated with topical application of 7,12-di
methylbenz[a]anthracene (DMBA) at a dose of 50 mu g or acetone alone on day
1 of the experiment, followed by treatment with 3.6 mg of DMA, 5 mu g of 1
2-O-tetradecanoylphorbol-13-acetate (TPA) or neutral: vehicle (control) twi
ce a week for 18 weeks. Mice were killed 1 week after the end of the treatm
ent. Induction of skin tumors was significantly accelerated in the DMA-trea
ted group, as well as in the TPA-treated group, indicating that DMA has a p
romoting effect on skin tumorigenesis in K6/0DC transgenic mice.